Based on the aforementioned evidence, we hypothesized in the present study that exosomal miR-30c may negatively regulate BCL9 and affect the activity of the Wnt/CD44 signaling pathway, thereby restricting the progression of EMs. This evidence concerns the gene CD44 and eosinophilia-myalgia syndrome.